Patents by Inventor Pierre Major

Pierre Major has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220396809
    Abstract: An engineered Newcastle Disease Virus (NDV) vector is provided. In particular, the present disclosure provides methods of treating or preventing a disease such as cancer, or an infectious disease, or methods for eliciting an immune response, with the engineered NDV vector. The engineered NDV vector provided herein is useful as an immunogenic composition, an oncolytic agent, or a vaccine.
    Type: Application
    Filed: June 3, 2022
    Publication date: December 15, 2022
    Inventors: Sarah Wootton, Leonardo Susta, Byram Bridle, Pierre Major, Lisa Santry, Yanlong Pei
  • Publication number: 20070077559
    Abstract: A mammalian subject having a tumor is treated by a method comprising administering an effective amount of a Newcastle disease virus, wherein the virus is administered to the subject in one or more cycles; and at least one cycle comprises administering sequentially one or more initial doses of from 1.8×1010 PFU to 4.8×1010 PFU of the virus per square meter of patient surface area followed by administering one or more subsequent doses of from 2.4×1010 PFU to 1.2×1011 PFU of the virus per square meter of patient surface area.
    Type: Application
    Filed: March 2, 2004
    Publication date: April 5, 2007
    Inventors: Michael Bamat, Robert Lorence, Pierre Major, Harvey Rabin, Michael Roberts
  • Publication number: 20040131595
    Abstract: A negative-stranded RNA virus is used to treat a mammalian subject having a carcinoid tumor.
    Type: Application
    Filed: November 3, 2003
    Publication date: July 8, 2004
    Applicant: Wellstat Biologics Corporation
    Inventors: Robert M. Lorence, Pierre Major